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Purpose
The National Cancer Screening Program (NCSP) began in 1999. The objective of this report is
to evaluate the results of the NCSP in 2008 and provide essential evidence associated with
the gastric cancer screening program in Korea.
Materials and Methods
Data was obtained from the National Cancer Screening Information System; participation
rates in gastric cancer screening were calculated. According to screening modalities, recall
rates were estimated with 95% confidence intervals (CIs).
Results
The target population of the gastric cancer screening program in 2008 was 7,132,820 Korean
men and women aged 40 and over, 2,076,544 of whom underwent upper endoscopy or upper
gastrointestinal (UGI) series as screening tools (participation rate, 29.1%). Disparities in
participation rates were observed relating to gender and health insurance type. Overall,
recall rates of upper endoscopy and UGI series were 3.1% (95% CI, 3.0 to 3.1) and 33.3% (95%
CI, 33.3 to 33.4), respectively.
Conclusion
According to our research, efforts to facilitate participation and to reduce disparities in
gastric cancer screening among Korean men and women are needed. These results will
provide essential data for evidence-based strategies in gastric cancer control in Korea.
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I n t r o d u c t i o n
Gastric cancer mortality has been decreasing continuously in Korea.
It is, however, still a clinically important disease due to its high
incidence and mortality [1,2]. To reduce high gastric cancer mortality,
as part of a comprehensive 10-year plan for cancer control, the
National Cancer Screening Program (NCSP) for Medical Aid Program
(MAP) recipients was initiated in 1999. The NCSP recommends that
men and women aged 40 or over undergo upper endoscopy or upper
gastrointestinal (UGI) series every other year [3]. When a UGI series is
chosen as a screening method, upper endoscopy can also be conducted
if gastric cancer is suspected. If necessary, a biopsy is conducted during
upper endoscopy.
The target population of NCSP was expanded to include National
Health Insurance (NHI) beneficiaries within the lower 20% of the
income bracket in 2002. This cut-off was increased to 30% in 2003 and
then to 50% in 2005. Currently, MAP recipients and NHI beneficiaries
in the lower 50% income bracket are eligible to be included in the
NCSP and can have gastric cancer screening free of charge (including
additional upper endoscopy and biopsy). The NHI Corporation has
also provided gastric cancer screening to its beneficiaries who are not
included in the NCSP and covers part of the cost of the screening
services through the NHI screening program. It subsidized 50% of the
cost of screening services until 2005. It subsequently increased its
subsidization to 80% in 2006 and then to 90% in 2010. 
The aim of this study was to evaluate results of the NCSP for gastric
cancer in 2008, to investigate the participation rate of gastric cancer
screening, and to assess the results.
M a t e r i a l s  a n d  M e t h o d s
Participants of the NCSP in 2008 were men and women who were
NHI beneficiaries within the lower 50% of the income bracket and
MAP recipients aged 40 or over, who were born in 1968 or before. For
those who were included in the NCSP among the NHI beneficiaries,
their insurance premium was US$56.5 (1 US$=1,000 won) per month
or below (based on November, 2007) for the employee insured and
US$67 per month or below for the self-employed insured.
Participation in the NCSP was confirmed from the claims and
results of gastric cancer screening submitted to the NHI Corporation
before December 31, 2009. Screening was performed between January
1, 2008 and December 31, 2008. Some subjects underwent the same
screening procedure multiple times; for these individuals only the first
screening was counted (n=2,239). Some subjects underwent UGI
series followed by endoscopy because gastric cancer was suspected
from the UGI series (n=5,719). These patients were only counted once
to give the participation rate. The participation rate of gastric cancer
screening was calculated by dividing the number of participants by the
target population of NCSP for gastric cancer, and denoted as a
percentile [4].
The results of the screening program were classified into six
categories: ‘normal,’ ‘benign,’ ‘needing further evaluation,’ ‘suspicious
of cancer,’ ‘gastric cancer,’ and ‘confirmed gastric cancer.’ ‘Needing
further evaluation’ was defined as needed additional examination due
to suspected gastric cancer, or the case where follow-up was required
within a short period. ‘Gastric cancer’ was defined as a case where
gastric cancer was confirmed in the biopsy during upper endoscopy.
‘Confirmed gastric cancer’ was defined as cases wherein the patient
already has a previous medical history of gastric cancer prior to
screening. In this study, participants falling within the categories
‘needing further evaluation,’ ‘suspicious of cancer,’ and ‘gastric
cancer’ were deemed to be recall cases. Subjects who underwent both
UGI series and upper endoscopy were defined as recall cases in UGI
series regardless of the final result. Recall rates for gastric cancer
screening were defined as the proportion of recall cases among the
cancer-screened participants. The 95% confidence intervals were
calculated for all outcome variables.
R e s u l t s
In the target population of 7,132,820 subjects for gastric cancer
screening, there were 3,407,649 (47.8%) males and 3,725,171 (52.2%)
females. Based on health insurance, 929,428 (13.0%) were covered by
MAP and 6,203,392 (87.0%) were covered by NHI. There were
330,870 over the age of 70 covered by MAP, accounting for 35.6% of
total MAP recipients. This was much higher than the 11% of NHI
beneficiaries falling in the same age group.
Of the target population, 2,076,544 participants underwent gastric
cancer screening, giving 29.1% participation. Of them, 58.6%
(1,216,690) were women and 41.4% (859,854) were men. For men,
there were 268,419 (31.2%) participants in their 50s, accounting for the
largest male group, whereas, for women, the largest group was women
in their 40s where there were 420,094 (34.5%) participants. For the
NHI beneficiaries, participation decreased as their age increased,
whereas, for MAP beneficiaries, participation increased as their age
increased. Thus, there were 55,036 participants in their 70s, accounting
for 32.1% of the total (Fig. 1). 
According to screening method, 1,198,061 (57.7%) participants
selected UGI series as a primary gastric cancer screening method,
whereas 878,483 (42.3%) participants selected upper endoscopy.
However, 385,062 subjects, (32.1%) who initially underwent UGI
series, also underwent upper endoscopy. Of the participants in their
50s, 34.2% of the individuals who underwent UGI series also
underwent upper endoscopy, accounting for the largest portion,
whereas 28.9% of the participants in their 70s or over additionally
underwent upper endoscopy, accounting for the smallest portion. For
participants in their 40s, 335,087 (50.5%) underwent upper endoscopy,
whereas 328,417 (49.5%) underwent UGI series. As age increased, the
participation rate decreased so that 56,845 participants in their 70s
underwent upper endoscopy, accounting for 22.4% of the total
participants in their 70s who participated in the gastric cancer screening
(Fig. 2).
The participation rate in gastric cancer screening in the 2008 NCSP
was 29.1%. In the target population, the female participation rate was
32.7%, which was higher than the males with a rate of 25.2%. As
participant age increased, so did the participation rate, to 39.7% in their
60s, which was the highest rate for both male and females (Fig. 3). This
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Fig. 1. Number of participants by health insurance type and age
from the National Cancer Screening Program, 2008.
figure decreased to 25.0% in those in their 70s and over. When the
participation rate was classified by insurance type, the participation rate
was 18.5% in MAP recipients, which was lower than 30.7% in NHI
beneficiaries (Fig. 4).
Of the 1,198,061 participants who underwent UGI series, 561,377
(46.9%) subjects were normal and 237,049 (19.8%) subjects were
benign. The recall cases were classified as 12,575 (1.0%) ‘needing
further evaluation,’ 386,634 (32.3%) ‘suspicious of cancer,’ and 127
(0.0%) as ‘gastric cancer.’ Of the total 878,483 participants who
underwent upper endoscopy, 113,829 (13.0%) were normal and
737,427 (83.9%) were benign. The recall cases were classified as
24,014 (2.7%) ‘needing further evaluation,’ 1,138 (0.1%) ‘suspicious
of cancer,’ and 1,798 (0.2%) as ‘gastric cancer.’ The recall rate for UGI
series was 33.3%, with the highest rate of 34.1% for participants in
their 40s. As participant age increased, the recall rate decreased, to
30.8%, the lowest rate being in participants aged 70 and over. The
recall rate of upper endoscopy was 3.1%, which was lower than that of
UGI series. As participant age increased, the recall rate increased
(Table 1).
D i s c u s s i o n
The participation rate in the NCSP for gastric cancer in 2008 was
29.1%. Trends for participation rates have been increasing con-
tinuously, from 12.7% in 2002 when the participation rate of gastric
cancer screening in the NCSP was first estimated. However, it is still
below the overall screening rate for gastric cancer in Korea (53.5%),
including opportunistic screenings as well as the organized screening
program conducted by the NHI Corporation [5].
In 1960, mass gastric screening by barium X-ray was started in
Miyagi Prefecture, Japan. In conformity with the Law of Health and
Medical Services for the Elderly, which came into effect in 1983,
gastric cancer screening has been conducted nationwide as a Japanese
government policy. Japanese men and women aged 40 or over were
recommended to participate annually in cancer screening programs for
gastric cancer with photofluorography using X-ray devices. Although
the Japanese government set a goal of an annual participation rate of
30% among the target population, the participation rate in gastric
cancer screening was 12.1% in 2006 [6-8].
In Korea, the participation rate in NCSP is higher than that of Japan,
but is lower than the participation rate of 60-70% in European
countries [9,10]. One reason that gastric cancer screening has not had a
higher take-up in the NCSP was the negative perception that the
quality of screening services was poor [11]. To facilitate participation
in NCSP, many hospitals and clinics were allowed to become a gastric
cancer screening facility if they met minimal requirements. This policy
increased the participation rate in NCSP, but also caused an issue with
the quality of the management of the cancer screening service. 
Kyung Sook Lee, et al_Gastric Cancer Screening in Korea
VOLUME 43  NUMBER 2  JUNE  2011  85
700,000
P
e
rs
o
n
(n
)
Age (yr)
0
60-6950-5940-49
500,000
300,000
600,000
400,000
200,000
100,000
Upper endoscopy
UGI series
>70
Fig. 2. Number of participants by screening modalities and age
from the National Cancer Screening Program, 2008. UGI, upper
gastrointestinal.
50
P
a
rt
ic
ip
a
ti
o
n
ra
te
(%
)
Age (yr)
0
60-6950-5940-49
30
40
20
10
Female
Male
>70
Fig. 3. Participation rates by gender and age from the National
Cancer Screening Program, 2008.
50
P
a
rt
ic
ip
a
ti
o
n
ra
te
(%
)
Age (yr)
0
60-6950-5940-49
30
40
20
10
Medical Aid Program
National Health Insurance
>70
Fig. 4. Participation rates by health insurance type and age
from the National Cancer Screening Program, 2008.
Cancer Res Treat. 2011;43(2):83-88
86 CANCER  RESEARCH AND  TREATMENT
Ta
rg
et
 
N
o.
 o
f 
Pa
rti
ci
pa
tio
n
U
G
I s
er
ie
s
U
pp
er
 e
nd
os
co
py
po
pu
la
tio
n
pa
rti
ci
pa
nt
s
ra
te
 (%
)
N
o.
 o
f
R
ec
al
l 
R
ec
al
l 
95
%
 C
I
N
o.
 o
f
R
ec
al
l
R
ec
al
l
95
%
 C
I
pa
rti
ci
pa
nt
s
ca
se
s (
n)
a)
ra
te
 (%
)
pa
rti
ci
pa
nt
s
ca
se
s (
n)
b)
ra
te
 (%
)
To
ta
l
7,
13
2,
82
0 
2,
07
6,
54
4 
29
.1
 
1,
19
8,
06
1 
39
9,
33
6 
33
.3
 
33
.3
-3
3.
4
87
8,
48
3 
26
,9
50
 
3.
1 
3.
0-
3.
1
G
en
de
r
M
al
e
3,
40
7,
64
9 
85
9,
85
4 
25
.2
49
1,
92
7
16
5,
95
3 
33
.7
 
33
.6
-3
3.
9
36
7,
92
7 
14
,0
42
 
3.
8 
3.
8-
3.
9
Fe
m
al
e
3,
72
5,
17
1 
1,
21
6,
69
0 
32
.7
 
70
6,
13
4 
23
3,
38
3 
33
.1
 
32
.9
-3
3.
2
51
0,
55
6 
12
,9
08
 
2.
5 
2.
5-
2.
6
H
ea
lth
 in
su
ra
nc
e 
ty
pe
N
H
I
6,
20
3,
39
2 
1,
90
4,
98
3 
30
.7
1,
07
6,
12
2 
36
1,
90
0 
33
.6
 
33
.5
-3
3.
7
82
8,
86
1 
25
,3
61
 
3.
1 
3.
0-
3.
1
M
A
P
92
9,
42
8 
17
1,
56
1 
18
.5
 
12
1,
93
9 
37
,4
36
 
30
.7
 
30
.4
-3
1.
0
49
,6
22
 
1,
58
9 
3.
2 
3.
1-
3.
4
A
ge
 g
ro
up
 (y
r)
40
-4
9
2,
79
0,
42
3 
66
3,
50
4 
23
.8
 
32
8,
41
7 
11
1,
89
9 
34
.1
 
33
.9
-3
4.
2
33
5,
08
7 
8,
59
3
2.
6 
2.
5-
2.
6
50
-5
9
2,
06
6,
30
4 
65
8,
27
6 
31
.9
 
35
9,
93
1 
12
6,
64
8
35
.2
 
35
.0
-3
5.
3
29
8,
34
5 
9,
06
0
3.
0 
3.
0-
3.
1
60
-6
9
1,
26
1,
59
7 
50
0,
64
9 
39
.7
 
31
2,
44
3 
10
0,
04
2 
32
.0
 
31
.9
-3
2.
2
18
8,
20
6 
6,
81
2 
3.
6 
3.
5-
3.
7
≥
70
1,
01
4,
49
6 
25
4,
11
5 
25
.0
 
19
7,
27
0 
60
,7
47
 
30
.8
 
30
.6
-3
1.
0
56
,8
45
 
2,
48
5 
4.
4 
4.
2-
4.
5
R
es
id
en
ce
 a
re
a
Se
ou
l
1,
29
0,
76
6 
33
2,
46
9 
25
.8
 
16
5,
41
2
41
,4
00
 
25
.0
 
24
.8
-2
5.
2
16
7,
05
7 
6,
42
4 
3.
8 
3.
8-
3.
9
B
us
an
58
1,
29
5 
17
9,
49
1 
30
.9
 
10
7,
54
5 
27
,9
85
 
26
.0
 
25
.8
-2
6.
3
71
,9
46
1,
55
0 
2.
2
2.
1-
2.
3
D
ae
gu
37
1,
55
0 
15
,2
89
 
31
.0
 
57
,2
05
 
19
,8
91
 
34
.8
 
34
.4
-3
5.
2
58
,0
84
 
1,
10
2 
1.
9 
1.
8-
2.
0
D
ae
je
on
18
3,
72
2 
62
,2
13
 
33
.9
 
35
,5
31
 
13
,6
36
 
38
.4
 
37
.9
-3
8.
9
26
,6
82
 
61
4 
2.
3 
2.
1-
2.
5
In
ch
eo
n
39
8,
47
0 
92
,6
76
 
23
.3
 
48
,6
53
 
11
,4
35
 
23
.5
 
23
.1
-2
3.
9
44
,0
23
 
3,
25
6 
7.
4 
7.
2-
7.
6
G
w
an
gj
u
18
5,
22
9 
51
,9
20
 
28
.0
 
25
,5
38
 
5,
98
5 
23
.4
 
22
.9
-2
4.
0
26
,3
82
 
78
3 
3.
0 
2.
8-
3.
2
U
ls
an
12
1,
57
6 
30
,6
15
 
25
.2
 
17
,1
02
 
4,
57
0 
26
.7
 
26
.1
-2
7.
4
13
,5
13
 
23
9 
1.
8 
1.
6-
2.
0
G
ye
on
gg
i
1,
43
8,
32
1 
37
7,
27
4 
26
.2
 
17
1,
44
1 
56
,1
64
 
32
.8
 
32
.5
-3
3.
0
20
5,
83
3 
5,
64
3 
2.
7 
2.
7-
2.
8
G
an
gw
on
25
9,
40
6 
86
,3
26
 
33
.3
 
68
,2
27
 
33
,8
96
 
49
.7
 
49
.3
-5
0.
1
18
,0
99
 
45
7 
2.
5 
2.
3-
2.
8
C
hu
ng
ch
eo
ng
bu
k
24
5,
68
7 
85
,7
84
 
34
.9
 
63
,4
97
 
23
,6
99
 
37
.3
 
37
.0
-3
7.
7
22
,2
87
 
77
2 
3.
5 
3.
2-
3.
7
C
hu
ng
ch
eo
ng
na
m
32
9,
71
6 
10
5,
57
7 
32
.0
 
71
,7
59
 
22
,5
04
 
31
.4
 
31
.0
-3
1.
7
33
,8
18
 
47
6 
1.
4 
1.
3-
1.
5
Je
ol
la
bu
k
32
8,
07
9 
10
8,
69
2 
33
.1
 
74
,8
07
 
23
,9
22
 
32
.0
 
31
.6
-3
2.
3
33
,8
85
 
99
8 
2.
9 
2.
8-
3.
1
Je
ol
la
na
m
36
3,
88
2 
12
2,
25
1 
33
.6
 
75
,6
93
 
20
,3
30
 
26
.9
 
26
.5
-2
7.
2
46
,5
58
 
1,
48
6 
3.
2 
3.
0-
3.
4
G
ye
on
gs
an
gb
uk
45
9,
18
0 
15
0,
77
5 
32
.8
 
96
,8
16
 
48
,0
51
 
49
.6
 
49
.3
-5
0.
0
53
,9
59
 
1,
62
7 
3.
0 
2.
9-
3.
2
G
ye
on
gs
an
gn
am
48
8,
20
3 
15
1,
00
9 
30
.9
 
10
0,
92
7 
40
,6
15
 
40
.2
 
39
.9
-4
0.
5
50
,0
82
 
1,
00
6 
2.
0 
1.
9-
2.
1
Je
ju
87
,7
38
 
24
,1
83
 
27
.6
 
17
,9
08
 
5,
25
3 
29
.3
 
28
.7
-3
0.
0
6,
27
5 
51
7 
8.
2 
7.
6-
8.
9
U
G
I, 
up
pe
r g
as
tro
in
te
sti
na
l; 
C
I, 
co
nf
id
en
ce
 in
te
rv
al
; N
H
I, 
N
at
io
na
l H
ea
lth
 In
su
ra
nc
e;
 M
A
P,
 M
ed
ic
al
 A
id
 P
ro
gr
am
. a
) P
ar
tic
ip
an
ts 
w
ho
 re
ce
iv
ed
 ‘n
ee
di
ng
 fu
rth
er
 e
va
lu
at
io
n,
’ ‘
su
sp
ic
io
us
 o
f c
an
ce
r,’
 o
r ‘
ga
str
ic
 c
an
ce
r’ 
or
 re
ce
iv
ed
 a
dd
iti
on
al
up
pe
r e
nd
os
co
py
 fo
r f
ur
th
er
 e
va
lu
at
io
n 
af
te
r u
nd
er
go
in
g 
U
G
I s
er
ie
s w
er
e 
de
em
ed
 to
 b
e 
re
ca
ll 
ca
se
s, 
b)
Pa
rti
ci
pa
nt
s w
ho
 re
ce
iv
ed
 ‘n
ee
di
ng
 fu
rth
er
 e
va
lu
at
io
n,
’ ‘
su
sp
ic
io
us
 o
f c
an
ce
r,’
 o
r ‘
ga
str
ic
 c
an
ce
r’ 
w
er
e 
de
em
ed
 to
 b
e 
re
ca
ll 
ca
se
s.
T
ab
le
 1
. S
cr
ee
ni
ng
 o
ut
co
m
es
 b
y 
ge
nd
er
, h
ea
lth
 in
su
ra
nc
e 
ty
pe
, a
ge
, a
nd
 a
re
a 
of
 re
si
de
nc
e 
fr
om
 th
e 
N
at
io
na
l C
an
ce
r S
cr
ee
ni
ng
 P
ro
gr
am
, 2
00
8
Kyung Sook Lee, et al_Gastric Cancer Screening in Korea
VOLUME 43  NUMBER 2  JUNE  2011  87
To address this issue and improve the quality of cancer screening
systematically, the government legislated for assessing and regulating
cancer screening facilities via an amendment to the Cancer Control Act
in 2006. The Quality Evaluation of National Cancer Screening
(QENCS) program, which has been conducted by the National Cancer
Center (NCC) since 2008, evaluates all aspect of cancer screening
including the structure, process, and outcome. In particular, for
outcome assessment, both participant satisfaction and the accuracy of
cancer screening are reviewed. Prior to the assessment, the NCC
developed and distributed ‘Quality guidelines of gastric cancer
screening’ with the help of professional associations to improve the
quality of gastric cancer screening. When the first term of the QENCS
program, which is in progress, is completed for 2010, more objective
and improved assessment items and standards will be developed.
The use of a photofluorographic device with 100 mm film will be
prohibited in UGI series starting from 2010 to improve imaging
quality. The standardized method of taking a series of films including
‘supine positioned double contrast image,’ ‘prone positioned single
contrast image,’ ‘erect compression image,’ ‘distal esophagus and
gastroesophageal junction image,’ and ‘right posterior and left posterior
oblique images (45o)’ has been recommended since 2010. Although
this lags the Japanese standardized method with the seven standard
images [12], the standardization of UGI series and an improvement in
screening performance can be expected as a result of this recom-
mendation.
Despite the increasing trend in participation in NCSP for gastric
cancer, there are some issues to be resolved. First, the incidence and
mortality of gastric cancer are known to be relatively high in the lower
socio-economic class in Korea [13]. Thus, the participation rate in
gastric cancer screening needs to be improved in these people.
However, the participation rate of MAP recipients increased from
12.6% in 2002 to 18.6% in 2008, which is lower than the rate of NHI
beneficiaries (12.7% in 2002; 30.7% in 2008). Despite gastric cancer
screening being free of charge, the poor participation rate of the socio-
economic lower class in gastric cancer screening indicates other factors
inhibit participation in gastric cancer screening apart from the
economic burden of screening costs. Thus, identification of factors that
inhibit participation in gastric cancer screening and suitable measures
to overcome these are required.
Second, incidence rates of gastric cancer based on gender are 61.2
males/100,000 persons and 23.9 females/100,000 persons, 2.6-fold
higher in males than females. Gastric cancer mortality is also 2.7-fold
higher in males than females (age-adjusted mortality rate per 100,000,
25.3 in males and 9.3 in females) [2]. Despite the high incidence and
mortality of gastric cancer in males, the male participation rate in
gastric cancer screening is lower than for females (age-adjusted
participation rate, 25.4% in males; 33.2% in females). Thus, to
decrease high gastric cancer mortality, efforts should be made to
increase the participation rate of gastric cancer screening in Korean
men.
Third, compared with the recall rate of 3.1% in upper endoscopy, the
recall rate was 33.3% in UGI series. This is attributable to the fact that
32.1% of the examinees who selected UGI series also underwent upper
endoscopy. In the NCSP, if UGI series is chosen as a gastric cancer
screening method, upper endoscopy can also be conducted free of
charge. However, due to the ambiguous indication of additional upper
endoscopy and free screening costs, unnecessary additional upper
endoscopy is likely to be conducted.
In Japan, the recall rate of gastric cancer screening in Osaka was
11.7% in the 1970s [14], with a minimum of 10.1% and maximum of
18.9% in the 1980s [15-19]. Since the 1990s, the recall rate was
recently reported to be approximately 10% [8,20]. At the beginning of
gastric cancer screening programs in Japan, recall rates were as high as
20%, but decreased continuously to 10%, which has now stabilized.
The category ‘suspicious of cancer’ will be clearly stated in the
requirement of conducting additional upper endoscopy starting from
2010 in the NCSP, which should reduce unnecessary additional upper
endoscopy.
The recall rate of upper endoscopy was 3.1%, maintaining the lower
level, but disparities, depending on geographical location, were
observed (age-adjusted recall rate range, 1.4 to 8.2%). In Korea, the
qualification of doctors who can conduct endoscopy including the
NCSP is not separately defined. In various foreign countries, to
conduct endoscopy, doctors are required to take supervised training to
reach a certain level of competence [21]. Additionally, to meet
increased endoscopy demand and provide qualified services due to the
introduction of a nationwide screening program using endoscopy,
development of a new educational and training program is required
[22]. The development of educational programs for endoscopists in the
NCSP is required to minimize variations and to provide upper
endoscopy at a consistent level.
Finally, there is the regional disparity of up to 11.6% in the
participation rate, ranging from 23.3% to 34.9%. There was no change
in the regional disparity even if the age was adjusted based on the
region (age-adjusted participation rate range, 23.5 to 35.1%).
According to the 2008 report, from a total of 249 regions across the
country, 10 areas were reported to be without gastric cancer screening
facilities (4.0%) [23]. In these areas, participants underwent gastric
cancer screening in other areas or via mobile screening units.
In 2008, essentially required medical devices for gastric cancer
screening were changed from ‘endoscope’ and ‘photoflorographic
apparatus’ to ‘endoscope’ to improve access to gastric cancer
screening. Through this modification, gastric cancer screening was
available in clinics and hospitals equipped only with devices for upper
endoscopy. Of the participants who underwent gastric cancer screening
in 2008, 42.3% selected upper endoscopy as a screening tool.
Considering additional upper endoscopy, more than half of the total
participants underwent this procedure. However, 54.6% of the
participants in Gyeonggi province underwent upper endoscopy for
gastric cancer screening, whereas only 21.0% of the participants in
Gangwon province underwent the same procedure. Regional
disparities exist not only in the number of gastric cancer screening
facilities but also in the number of hospitals and clinics that provide
upper endoscopy. Thus, continuing efforts are required for more
medical centers to participate in the NCSP, as well as investment in
public hospitals to resolve areas with no screening unit.
C o n c l u s i o n
In 2008, 29.1% of the target population of NCSP participated in
gastric cancer screening. Differences in participation rate occurred
between regions, age, and socioeconomic status. Additionally,
differences existed in the selection of gastric cancer screening methods.
Thus, along with improving the participation rate in gastric cancer
screening, continuing efforts are required to minimize these
differences.
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